Peptide questions · Abaloparatide

Abaloparatide side effects: what studies and users report

Reviewed Evidence: EstablishedPublished by PepVault

The side effects most commonly reported for abaloparatide are injection site redness, dizziness and nausea, among 7 the library lists; the library’s evidence on it includes controlled trials in people.

Its safety note opens: The current Tymlos label has no boxed warning.

What is commonly reported with abaloparatide

  • Injection site redness
  • Dizziness
  • Nausea
  • Headache
  • Palpitations
  • Fatigue
  • High urine calcium

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other healing & recovery compounds the library lists it for
EffectAlso listed for (of 18)
Injection site rednessNone: listed for Abaloparatide alone
Dizziness2: BPC-157, Teriparatide
Nausea6: BPC-157, TB-500, AOD-9604, Larazotide and 2 more
Headache6: TB-500, Thymosin Beta-4, Linaclotide, VIP and 2 more
PalpitationsNone: listed for Abaloparatide alone
Fatigue5: TB-500, Thymosin Alpha-1, Thymosin Beta-4, ARA-290 and 1 more
High urine calciumNone: listed for Abaloparatide alone
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track abaloparatide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which abaloparatide side effects the healing & recovery group shares

Across the 19 healing & recovery compounds in the library, the effects listed most often are headache (7 of 19), injection site reaction (7 of 19), nausea (7 of 19) and fatigue (6 of 19). Abaloparatide shares 4 of its 7 listed effects with at least one other healing & recovery compound; injection site redness, palpitations and high urine calcium are listed for abaloparatide alone.

What the abaloparatide safety notes say

The library’s safety note

The current Tymlos label has no boxed warning. In a 2-year rat study, osteosarcoma rose with dose at every dose tested (up to 87% of males and 62% of females at the highest, against 0-2% of controls); whether it does so in people is unknown, observational studies of PTH analogs have not shown a raised risk, and data beyond 2 years are limited. The label avoids it in anyone with a raised baseline risk: growing bones, Paget's disease or another bone disease, bone cancer or metastases, or radiation to the skeleton. A drop in blood pressure on standing can come within 4 hours of a shot, with dizziness, a racing heart or nausea, so the first doses are given sitting or lying down; heart rate rose 15 beats per minute on average shortly after a dose and settled within about 6 hours. It can raise blood and urine calcium, so it is not used with a high-calcium disorder. Serious allergic reactions have been reported. These are label findings; review them with your clinician.

The library’s interaction note

No drug-interaction studies have been done (label). Calcium and vitamin D are added if the diet falls short. No trial has combined it with teriparatide; both act on the same receptor, and each label limits use to about 2 years in a lifetime. Discuss all your medicines with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Where the abaloparatide reports come from

The library rates the evidence on abaloparatide as established: clinical trials or FDA-approved use exist.

Of the library’s 6 research notes on abaloparatide, 5 rest on randomized trials and 1 on community reports.

Our 8 study pages on abaloparatide: 2 meta-analyses, 5 randomized trials and 1 clinical trial.

So abaloparatide has controlled trials in people to set its listed effects against.

What our abaloparatide study pages report on safety

Abaloparatide, teriparatide beat other drugs on spine BMD in men

Meta-analysis, human, 2025: On safety, teriparatide did best for all adverse events, and oral bisphosphonates did best for lowering severe adverse events. In men with osteoporosis, abaloparatide was among the top options for spine and femoral neck bone density, but it did not lead on total hip density or on side effects.

Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks

Meta-analysis, human, 2023: Serious side effects and deaths showed no clear difference between the drugs, and hypercalcemia, too much calcium in the blood, was 51% less common with abaloparatide than with teriparatide. Compared with placebo, abaloparatide carried higher risks of nausea and palpitations.

Abaloparatide then alendronate: 84% lower vertebral fracture risk

Randomized trial, human, 2018: A separate analysis found no hip fractures in the abaloparatide group while the placebo group had some, and side effects were similar between groups.

Abaloparatide: normal bone biopsies after up to 18 months in ACTIVE

Randomized trial, human, 2017: For abaloparatide users, this adds tissue-level evidence that up to 18 months of treatment in ACTIVE did not raise bone safety concerns in biopsies.

Questions people ask

What are the side effects of abaloparatide?

The side effects most commonly reported for abaloparatide are injection site redness, dizziness and nausea, among 7 the library lists; the library’s evidence on it includes controlled trials in people.

Do abaloparatide’s side effects come from human studies?

The library rates the evidence on abaloparatide as established, and the library’s evidence on it includes controlled trials in people.

Which abaloparatide side effects are its own?

Among the healing & recovery compounds, the library lists injection site redness, palpitations and high urine calcium for abaloparatide alone.

Does abaloparatide interact with other medicines?

The library’s interaction note on abaloparatide begins: No drug-interaction studies have been done (label).

More on abaloparatide

Track it in the app

PepVault for iPhone

Track abaloparatide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo